Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Stem Cell Research & Therapy|July 6, 2018
An improvised one-step sucrose cushion ultracentrifugation method for exosome isolation from culture supernatants of mesenchymal stem cellsSuchi Gupta, Sonali Rawat, Vivek Arora, et al.
Human Vaccines & Immunotherapeutics|October 7, 2024
Long-term effectiveness of the nine-valent human papillomavirus vaccine: Interim results after 12 years of follow-up in Scandinavian womenSusanne K Kjaer, Thea E Hetland Falkenthal, Karin Sundström, et al.
Stem Cell Research & Therapy|March 29, 2025
Autoimmunity and clinical pathology amelioration in SLE by dexamethasone primed mesenchymal stem cell derived conditioned mediaKhushbu Priya, Sonali Rawat, Doli Das, et al.
Frontiers in Physiology|July 17, 2024
Mitochondrial dysfunction and its association with age-related disordersIndumathi Somasundaram, Samatha M Jain, Marcel Blot-Chabaud, et al.
Contemporary Clinical Trials|October 22, 2021
Design of a phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in menAnna R Giuliano, Timothy Wilkin, Oliver M Bautista, et al.
Nanomedicine (London, England)|August 25, 2021
Graphene nanofiber composites for enhanced neuronal differentiation of human mesenchymal stem cellsSonali Rawat, Krishan Gopal Jain, Deepika Gupta, et al.
Mitochondrion|January 18, 2024
Whole genome sequencing followed by functional analysis of genomic deletion encompassing ERCC8 and NDUFAF2 genes in a non-consanguineous Indian family reveals dysfunctional mitochondrial bioenergetics leading to infant mortalityAnkit Sabharwal, Vishu Gupta, Shamsudheen Kv, et al.
Vaccine|March 7, 2021
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age: An open-label phase 3 studyElmar A Joura, Angels Ulied, Corinne Vandermeulen, et al.
Pageof 2